All product descriptions and articles provided on this website are intended strictly for informational and educational purposes. Our products are designed exclusively for in-vitro research (i.e., experiments conducted outside of a living organism, typically in glassware such as test tubes or petri dishes). These compounds are not approved by the FDA for use in humans or animals. They are not medications, nor are they intended to diagnose, treat, prevent, or cure any disease or medical condition. Any bodily administration-human or animal-is strictly prohibited by law. Our products are not for human consumption under any circumstances.
A peptide is one of biochemistry’s most fundamental building blocks: two or more amino acids joined by peptide bonds. This overview surveys what peptides are, how the bond forms, how nature and the laboratory assemble them, and how researchers classify the many families that result.
Key takeaways
- A peptide is a chain of amino acids linked by peptide (amide) bonds, formed in a condensation reaction that releases a molecule of water.
- Nature builds peptides two ways: on the ribosome (translated from mRNA) and off the ribosome, on modular nonribosomal peptide synthetase enzymes.
- In the laboratory, solid-phase peptide synthesis is the workhorse method for assembling defined sequences.
- Size is the usual dividing line — dipeptides, oligopeptides, and polypeptides — with larger chains (roughly 40–50+ residues) generally called proteins, though exceptions exist.
- The peptides Qovigen supplies are chemically defined reference materials for laboratory research use only (RUO), not products for human or veterinary use.
On this page
What is a peptide?
A peptide is a biologically occurring chemical compound made of two or more amino acids connected to one another by peptide bonds. Amino acids are the alphabet of this chemistry: each is a small molecule carrying both an amine group (–NH2) and a carboxyl group (–COOH). The alpha-amino acids are the specific building blocks from which biological peptides are constructed, and the order in which they are strung together — the peptide sequence — is what distinguishes one peptide from another.1
The linkage itself is the defining feature. A peptide bond is a covalent bond formed when the carboxyl group (the C-terminus) of one amino acid reacts with the amino group (the N-terminus) of another. The reaction is a condensation: as the two groups join, a single molecule of water is released. The result is a –CO–NH– linkage, which is an amide bond — so a peptide bond and an amide bond are the same chemistry. In living cells, this bond-forming step is catalyzed at the peptidyl transferase center of the ribosome, and biochemical studies continue to dissect exactly how that catalysis achieves its speed.3
The word “peptide” itself descends from the Greek péssein, meaning “to digest.” Peptides are ubiquitous in nature: thousands occur across human and animal biology as hormones, signaling molecules, and structural fragments, and new sequences are discovered and synthesized in the laboratory on a continual basis.1
Peptides versus proteins: a question of size
Peptides are usually classified by how many amino acids they contain. The shortest possible peptide, built from just two amino acids, is a dipeptide; three amino acids make a tripeptide. Oligopeptides are short chains of relatively few residues — generally fewer than about ten — while polypeptides are longer, typically more than ten. Much longer chains, generally those beyond roughly 40–50 amino acids, are usually referred to as proteins.
The boundary is a convention rather than a hard law of chemistry, and exceptions are common. Some longer peptides are conventionally called proteins (amyloid beta is often discussed in protein terms), while certain small proteins are historically called peptides — insulin being the classic example. The distinction matters less for the underlying chemistry, which is identical, than for how researchers talk about the molecules.
| Term | Approximate size | Illustrative example |
|---|---|---|
| Dipeptide | 2 amino acids | Carnosine |
| Tripeptide | 3 amino acids | Glutathione |
| Oligopeptide | ~4–10 amino acids | Oxytocin (9 residues) |
| Polypeptide | ~10–40 amino acids | Glucagon (29 residues) |
| Protein | ~40–50+ amino acids | Insulin (51 residues) |
Sizes shown are approximate conventions; the peptide/protein cut-off varies between sources and disciplines.
How nature builds peptides
Living systems assemble peptides by two fundamentally different routes, and the route determines much about the molecule’s structure.
Ribosomal peptides
The first and most familiar route is translation. Ribosomal peptides are produced when the ribosome reads messenger RNA and links amino acids in the sequence encoded by the gene, forming each peptide bond at its catalytic core.3 These peptides frequently act as hormones and signaling molecules — families include the tachykinins, vasoactive intestinal peptides, opioid peptides, pancreatic peptides, and calcitonin-related peptides. Many are synthesized as longer precursors and then trimmed by proteolysis (the enzymatic cutting of proteins into smaller peptides or amino acids) to reach their mature, active form. A rapidly growing subfield studies ribosomally synthesized and post-translationally modified peptides (RiPPs), in which enzymes chemically decorate a ribosome-made backbone to expand its structural range.6
Nonribosomal peptides
The second route bypasses the ribosome entirely. Nonribosomal peptides are built by large, modular enzymes called nonribosomal peptide synthetases (NRPS), which operate like molecular assembly lines: each module selects, activates, and adds one building block, passing the growing chain along.4 Within each module, an adenylation domain acts as the gatekeeper that chooses which amino acid is incorporated — and because these enzymes are not restricted to the standard genetically encoded amino acids, nonribosomal peptides can contain unusual and non-proteinogenic residues.5 They are frequently cyclic rather than linear and can adopt intricate ring architectures; they appear abundantly in bacteria, fungi, and plants. Many clinically studied antibiotics, such as the depsipeptide daptomycin, arise from this nonribosomal machinery.7 Glutathione — a thiol tripeptide that is central to cellular antioxidant defense — is the most abundant low-molecular-weight thiol synthesized in cells, assembled enzymatically rather than on the ribosome.10
Peptides from digestion and fermentation
Peptides also appear when larger proteins are broken down. Milk peptides, for instance, are released from milk proteins either by digestive enzymes or by the proteinases of lactobacilli during fermentation; multi-omics profiling of fermented milk has catalogued thousands of such sequences, some with reported angiotensin-converting-enzyme-inhibitory, antioxidant, and antimicrobial activity in laboratory assays.9 Peptones — peptide mixtures produced by proteolytic digestion of animal milk or meat — are used routinely in laboratories as nutrient media for growing bacteria and fungi. Peptide fragments generated by controlled enzymatic degradation of a sample, or arising naturally from degradation, are another everyday product of this hydrolytic route.
How the laboratory builds peptides
Chemists can now construct a virtually unlimited range of defined peptides, and modern peptide science is inseparable from the synthetic methods that make this possible.2 Two broad strategies exist. Liquid-phase (solution) peptide synthesis carries out the coupling chemistry in solution and retains some advantages for large-scale manufacture of short sequences. Solid-phase peptide synthesis (SPPS), however, is the standard technique for most research work: the growing chain is anchored to an insoluble resin bead, amino acids are added one at a time under protecting-group control, and excess reagents are simply washed away between steps. That wash-and-repeat cycle is what makes automated, high-fidelity assembly of long sequences practical.2
The field’s trajectory has been shaped by a handful of milestones. Early synthetic peptide chemistry dates to the turn of the twentieth century, and by the 1950s the first peptide hormone had been chemically synthesized — work later recognized with a Nobel Prize. Advances in peptide chemistry and molecular biology through the following decades turned peptides from laboratory curiosities into one of the most productive classes in drug discovery.1 Purity and identity are verified using analytical tools such as high-performance liquid chromatography and mass spectrometry, and techniques like peptide mapping and peptide fingerprinting help confirm that a synthesized sequence matches its intended structure.
Classes and key structural terms
Beyond the ribosomal/nonribosomal divide, several structural terms recur throughout the peptide literature and are worth defining clearly.
- Cyclic peptides. Here the amino-acid chain closes into a ring rather than ending in free termini. Backbone cyclization — sometimes combined with internal disulfide bracing, as in the plant cyclotides — can make these molecules markedly more resistant to thermal, chemical, and enzymatic degradation than their linear counterparts, which is why they attract interest as research scaffolds.8 Familiar cyclic or constrained examples include Melanotan II and PT-141 (bremelanotide).
- Peptide mimetics. Molecules designed to imitate the active shape or function of a natural peptide ligand — of a hormone, cytokine, enzyme substrate, or other biomolecule. A mimetic may be a modified natural peptide or an entirely non-peptide compound that reproduces the same binding behavior.
- Peptide mapping and fingerprinting. Analytical approaches that cleave a peptide or protein into fragments (enzymatically or by partial hydrolysis) and read the resulting fragment pattern to validate or discover a sequence.
- Peptide libraries. Large, systematically varied collections of peptides — often prepared by solid-phase synthesis — used to screen sequence space in biochemical and pharmaceutical research. Display-based libraries are now a mainstay of modern peptide drug discovery.1
Why peptides matter in research
Peptides occupy a distinctive niche between small-molecule drugs and large biologic proteins: they are large enough to bind targets with high specificity, yet small enough to be made by chemical synthesis. Since the introduction of insulin roughly a century ago, more than eighty peptide-based drugs have reached the market across fields as varied as metabolism, oncology, and endocrinology, and the pipeline continues to expand as production, modification, and analytical technologies mature.12 That same versatility is why individual research peptides — from BPC-157 to growth-hormone-secretagogue analogs — are studied so intensively in preclinical and in vitro models.
For laboratory work, three properties matter most: a correctly assembled sequence, verified identity and purity, and reproducibility from batch to batch. These are the reasons peptides intended for research are characterized analytically and accompanied by documentation rather than treated as interchangeable commodities.
Frequently asked questions
References
- Muttenthaler M, King GF, Adams DJ, Alewood PF. Trends in peptide drug discovery. Nat Rev Drug Discov. 2021;20(4):309–325. link
- Wang L, Wang N, Zhang W, et al. Therapeutic peptides: current applications and future directions. Signal Transduct Target Ther. 2022;7(1):48. link
- Bao L, Forster AC. Fast peptide bond formation and release by the ribosomal large subunit. J Biol Chem. 2025;301(7):110336. link
- Bozhüyük KAJ, Micklefield J, Wilkinson B. Engineering enzymatic assembly lines to produce new antibiotics. Curr Opin Microbiol. 2019;51:88–96. link
- Stanišić A, Kries H. Adenylation domains in nonribosomal peptide engineering. Chembiochem. 2019;20(11):1347–1356. link
- Duan L, Shah SMA, Huang K, et al. Bacillus as an engineered platform for antimicrobial peptide biosynthesis: from chassis design to agricultural applications. Pestic Biochem Physiol. 2026;221:107163. link
- Guglya EB, Shcheglov AS, Yampolsky IV. Antibacterial depsipeptides: one common feature, diversity of structures and mechanisms of action. Curr Med Chem. 2026 (Epub). link
- Cândido ES, Gasparetto LS, Maximiano MR, Rios TB, Franco OL. Cyclotides from plants driving the next generation of antibacterial agents. Antibiotics (Basel). 2026;15(6):604. link
- Shokrollahi B, Choi JY, Won M, Kim ET, Lee SE, Ham JS. Koumiss (fermented mare’s milk) as a functional food: bioactive proteins, peptides, and future perspectives. Foods. 2025;14(22):3954. link
- Forman HJ, Zhang H, Rinna A. Glutathione: overview of its protective roles, measurement, and biosynthesis. Mol Aspects Med. 2009;30(1–2):1–12. link
All Qovigen peptides are sold for laboratory and research use only (RUO). Not for human or veterinary use, diagnosis, or treatment.
